EUCTR2005-004532-43-DE进行中（未招募）不适用
Treatment of extraesophageal manifestations of laryngopharyngeal reflux with Nexium (esomeprazole) 20mg bid, a doubleblind placebo controlled study
Klinikum Großhadern, ENT-Department0 个研究点目标入组 64 人开始时间: 2005年11月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Globus sensation, hoarseness, heartburn, chronic cough, voice weakness, throat clearing, choking episodes, postnasal drip, dysphagia
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •To take proton pump inhibitors or H2-blockers, being under treatment with warfarin, pregnancy oin female patients, history of surgery of the upper aero digestive tract and gastro intestinal tract, age younger than 18
研究者
相似试验
已完成
2 期
Multi-Modality Treatment of Resectable Oesophageal Adenocarcinoma using Peri-operative Chemotherapy with additional Pre-operative Combined Radiotherapy and Cetuximaboesophageal adenocarcinoma1001799010017991NL-OMON39545niversitair Medisch Centrum Utrecht40
尚未招募
不适用
Managing problems of any food or bone or object impaction in food tract during Covid pandemicCTRI/2021/01/030212Karpaga Vinayaga Institute of Medical Sciences
撤回
不适用
Palliation of Obstructive Local Disease of the Esophagus by Radiotherapy10017991esophageal carcinomaesophageal cancerNL-OMON42160Academisch Medisch Centrum210
尚未招募
3 期
Homoeopathic treatment of respiratory sequelae of post- covid cases: an open label prospective studyCTRI/2021/03/032225Dr Anil Khurana
已完成
不适用
Esophageal motility disorders caused by esophageal eosinophiliaJPRN-UMIN000032377Gunma University Hospital18